1. Home
  2. MAIA vs HOLO Comparison

MAIA vs HOLO Comparison

Compare MAIA & HOLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • HOLO
  • Stock Information
  • Founded
  • MAIA 2018
  • HOLO 2018
  • Country
  • MAIA United States
  • HOLO China
  • Employees
  • MAIA N/A
  • HOLO N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • HOLO Computer Software: Programming Data Processing
  • Sector
  • MAIA Health Care
  • HOLO Technology
  • Exchange
  • MAIA Nasdaq
  • HOLO Nasdaq
  • Market Cap
  • MAIA 56.3M
  • HOLO 66.3M
  • IPO Year
  • MAIA 2022
  • HOLO N/A
  • Fundamental
  • Price
  • MAIA $1.59
  • HOLO $4.38
  • Analyst Decision
  • MAIA
  • HOLO
  • Analyst Count
  • MAIA 0
  • HOLO 0
  • Target Price
  • MAIA N/A
  • HOLO N/A
  • AVG Volume (30 Days)
  • MAIA 375.5K
  • HOLO 1.5M
  • Earning Date
  • MAIA 08-11-2025
  • HOLO 08-10-2023
  • Dividend Yield
  • MAIA N/A
  • HOLO N/A
  • EPS Growth
  • MAIA N/A
  • HOLO N/A
  • EPS
  • MAIA N/A
  • HOLO 13.81
  • Revenue
  • MAIA N/A
  • HOLO $44,840,587.00
  • Revenue This Year
  • MAIA N/A
  • HOLO N/A
  • Revenue Next Year
  • MAIA N/A
  • HOLO N/A
  • P/E Ratio
  • MAIA N/A
  • HOLO $0.32
  • Revenue Growth
  • MAIA N/A
  • HOLO 37.10
  • 52 Week Low
  • MAIA $1.40
  • HOLO $4.16
  • 52 Week High
  • MAIA $3.74
  • HOLO $375.20
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 50.99
  • HOLO 42.52
  • Support Level
  • MAIA $1.46
  • HOLO $4.42
  • Resistance Level
  • MAIA $1.65
  • HOLO $5.06
  • Average True Range (ATR)
  • MAIA 0.09
  • HOLO 0.30
  • MACD
  • MAIA 0.01
  • HOLO 0.01
  • Stochastic Oscillator
  • MAIA 43.10
  • HOLO 10.75

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About HOLO MicroCloud Hologram Inc.

MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library. Geographically company is operating in single segment, China.

Share on Social Networks: